Importantly, the sensitivity profile of AM-1882 aligns with KIF18A-KD and -KO gene dependency scores across cancer cell lines, suggesting that the mode of action of AM-1882 is chiefly driven by inhibition of KIF18A. The gene discussed is KIF18A; the disease is cancer.